mesalamine

(redirected from Delzicol)
Also found in: Medical.

me·sal·a·mine

 (mə-săl′ə-mēn′)
n.
A salicylate drug derived from sulfasalazine, C7H7NO3, used primarily to treat inflammatory bowel disease.
[me(ta)- + sal(icylic acid) + amine.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

mesalamine

(USAN), mesalazine (INN) n mesalamina, mesalazina (INN)
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
M2 PHARMA-May 16, 2019-Teva Launches of a Generic Version of Delzicol Delayed-Release Capsules in the United States
Teva Launches of a Generic Version of Delzicol Delayed-Release Capsules in the United States
Warner simultaneously introduced a similar but not exactly identical substitute drug called Delzicol, the patent protection for which ran years longer.
Consumer protection - Antitrust - Patent and trademark
The medicine will be marketed as Delzicol. It is indicated for the treatment of patients with mild to moderate active ulcerative colitis, and to maintain remission of the disease.
Warner Chilcott receives approval for mesalamine product
M2 EQUITYBITES-February 6, 2013-Warner Chilcott plc wins FDA approval for new ulcerative colitis capsule, DELZICOL 400 mg(C)2013 M2 COMMUNICATIONS http://www.m2.com
Warner Chilcott plc wins FDA approval for new ulcerative colitis capsule, DELZICOL 400 mg
Dictionary browser ?
Full browser ?